Next Article in Journal
Safety and Immunogenicity of a Plant-Produced Recombinant Hemagglutinin-Based Influenza Vaccine (HAI-05) Derived from A/Indonesia/05/2005 (H5N1) Influenza Virus: A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study in Healthy Adults
Next Article in Special Issue
Biogenesis and Dynamics of the Coronavirus Replicative Structures
Previous Article in Journal
Insight into Alternative Approaches for Control of Avian Influenza in Poultry, with Emphasis on Highly Pathogenic H5N1
Previous Article in Special Issue
Human Coronaviruses: Insights into Environmental Resistance and Its Influence on the Development of New Antiseptic Strategies
Viruses 2012, 4(11), 3209-3226; doi:10.3390/v4113209

Notes on Article Versions

NoteDate
article html file updated24 January 2013 08:31 CET
article html file updated7 February 2013 16:44 CET
article supplementary file uploaded.30 May 2013 16:36 CEST
Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert